IP Library Granted Patent US 9,458,499
Granted Patent B2
US 9,458,499 · App. 14/960,589 · Granted Oct 4, 2016

Nucleic acid binding dyes and uses therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,458,499
App. No.
14/960,589
Granted
Oct 4, 2016
Kind
B2
Abstract

The invention provides novel compounds and compositions of Formulas I and II, as well as methods of using them. The compounds can be used, for example, to quantify an amount of double stranded DNA in a sample subjected to nucleic acid amplification, or for real time monitoring of a nucleic acid amplification reaction. The compounds can be provided in a kit, for example, with other reagents and instructions for using the compounds and reagents.

Claims (27)

1. A method determining cell viability, comprising:

a) contacting a sample comprising a cell with a compound according to Formula 1:

wherein

R 1 , R 2 and R 3 are each H

Y is S or O;

W taken together with the atoms to which it is attached is a 6-membered heterocyclic ring;

n is 0;

Q is Q2:

wherein

Y is —CR 13 ═CR 14 —; m is 1 and p is 0;

R 6 is unsubstituted (C 1 -C 8 )alkyl, unsubstituted aryl, or unsubstituted (C 1 -C 8 )alkaryl;

R 9 , R 11 , and R 12 are each independently H, amino, or halo;

R 10 is H, methoxy, amino or halo;

one of R 13 and R 14 is H and the other is NR 15 R 16 ;

R 15 is (C 1 -C 6 )alkyl or (C 1 -C 6 )alkyl-NR 17 R 18 or C 3 H 7 —N + (CH 3 ) 3 wherein R 17 and R 18 are each independently H or (C 1 -C 6 )alkyl; and

R 16 is (C 1 -C 6 )alkyl-NR 17 R 18 or C 3 H 7 —N + (CH 3 ) 3 , wherein R 17 and R 18 are each independently H or (C 1 -C 6 )alkyl;

wherein at least one of R15 and R16 is C 3 H 7 —N + (CH 3 ) 3 ;

or a salt thereof;

b) detecting a fluorescent signal in the sample; and

c) correlating the amount of fluorescence in the sample with the viability of the cell in the sample;

wherein an increase in the fluorescent signal correlates to a loss in cell membrane integrity.

2. The method of claim 1 , wherein the compound is impermeant to the cell membrane.

3. The method of claim 1 , wherein the loss in cell membrane integrity indicates cell death.

4. The method of claim 3 , wherein cell death is due to a cytotoxic effect of a test treatment or condition on the cell.

5. The method of claim 1 , further comprising a counterstain comprising a detectably different signal to correlate metabolically active cells.

6. The method of claim 5 , further comprising a counterstain comprising a detectably different signal to differentiate cells with a loss in cell membrane integrity and cells with intact cell membranes.

7. The method of claim 1 , wherein the compound is:

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2015
From: MCDOUGALL, MARK; DWIGHT, STEPHEN
To: PROMEGA CORPORATION
Reel/Frame 037222/0379 →